SCT: False Claims Act Actions Based Upon Fraudulently Obtained Patent Rights
Patently-O
APRIL 25, 2024
Over the past several years, patent attorney Zachary Silbersher has been pursuing FCA qui tam lawsuits against pharmaceutical companies who allegedly fraudulently obtain patent rights and then use those exclusive rights to charge the Federal Government high prices for the resulting drugs. Int’l, Inc. , Greene’s Energy Grp.,
Let's personalize your content